These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19127276)

  • 1. Sarcopenia and the elusive fountain of youth.
    Hanauer SB
    Nat Clin Pract Gastroenterol Hepatol; 2009 Jan; 6(1):1. PubMed ID: 19127276
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ghrelin and bone metabolism].
    Komatsu Y; Nakao K
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():384-7. PubMed ID: 15506410
    [No Abstract]   [Full Text] [Related]  

  • 3. Update on new therapeutic options for the somatopause.
    Ceda GP; Dall'Aglio E; Morganti S; Denti L; Maggio M; Lauretani F; Andrea A; Ceresini G; Cattabiani C; Valenti G
    Acta Biomed; 2010; 81 Suppl 1():67-72. PubMed ID: 20518193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone and insulin-like growth factor-I as an endocrine axis in Alzheimer's disease.
    Gómez JM
    Endocr Metab Immune Disord Drug Targets; 2008 Jun; 8(2):143-51. PubMed ID: 18537700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sarcopenia].
    Rolland Y; Vellas B
    Rev Med Interne; 2009 Feb; 30(2):150-60. PubMed ID: 18829138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-associated sarcopenia--issues in the use of testosterone as an anabolic agent in older men.
    Bhasin S; Tenover JS
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1659-60. PubMed ID: 9177358
    [No Abstract]   [Full Text] [Related]  

  • 7. Growth hormone secretagogues: mechanism of action and use in aging.
    Fuh VL; Bach MA
    Growth Horm IGF Res; 1998 Feb; 8(1):13-20. PubMed ID: 10990440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial.
    Nass R; Pezzoli SS; Oliveri MC; Patrie JT; Harrell FE; Clasey JL; Heymsfield SB; Bach MA; Vance ML; Thorner MO
    Ann Intern Med; 2008 Nov; 149(9):601-11. PubMed ID: 18981485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure.
    Svensson J; Lönn L; Jansson JO; Murphy G; Wyss D; Krupa D; Cerchio K; Polvino W; Gertz B; Boseaus I; Sjöström L; Bengtsson BA
    J Clin Endocrinol Metab; 1998 Feb; 83(2):362-9. PubMed ID: 9467542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Summaries for patients. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults.
    Ann Intern Med; 2008 Nov; 149(9):I-36. PubMed ID: 18981483
    [No Abstract]   [Full Text] [Related]  

  • 11. Anabolic interventions in ESRD: light at the end of the tunnel?
    Hakim RM; Ikizler TA
    Am J Kidney Dis; 2009 Aug; 54(2):201-4. PubMed ID: 19556045
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of IGF-I in muscular atrophy of aging.
    Borst SE; Lowenthal DT
    Endocrine; 1997 Aug; 7(1):61-3. PubMed ID: 9449034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fast progressive development of marked hypotonia].
    Rute-Ferreira A; Marta R; Rocha S; Didelet C; Gonçalves-Rodrigues E
    Rev Neurol; 2009 Dec 1-15; 49(11):612-3. PubMed ID: 19921630
    [No Abstract]   [Full Text] [Related]  

  • 14. Sarcopenia: effects on body composition and function.
    Roubenoff R
    J Gerontol A Biol Sci Med Sci; 2003 Nov; 58(11):1012-7. PubMed ID: 14630883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palliative care pharmacotherapy literature summaries and analyses.
    Abernethy AP
    J Pain Palliat Care Pharmacother; 2009; 23(2):174-81. PubMed ID: 19492222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Finding the way into the brain without MCT8.
    Visser WE; Visser TJ
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4362-5. PubMed ID: 23223483
    [No Abstract]   [Full Text] [Related]  

  • 17. Allan-Herndon-Dudley-Syndrome: Considerations about the Brain Phenotype with Implications for Treatment Strategies.
    Krude H; Biebermann H; Schuelke M; Müller TD; Tschöp M
    Exp Clin Endocrinol Diabetes; 2020 Jun; 128(6-07):414-422. PubMed ID: 32242326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of ghrelin treatment for unloading-induced muscle atrophy in mice.
    Koshinaka K; Toshinai K; Mohammad A; Noma K; Oshikawa M; Ueno H; Yamaguchi H; Nakazato M
    Biochem Biophys Res Commun; 2011 Aug; 412(2):296-301. PubMed ID: 21820418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rejuvenation in older adults receiving oral ghrelin.
    Rafael H
    Ann Intern Med; 2009 May; 150(9):653-4; author reply 655. PubMed ID: 19414850
    [No Abstract]   [Full Text] [Related]  

  • 20. Rejuvenation in older adults receiving oral ghrelin.
    Gaugg M
    Ann Intern Med; 2009 May; 150(9):654; author reply 655. PubMed ID: 19414852
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.